$OKTA
Okta Inc Stock $okta

$okta Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000162828017006320 Filed on June 08, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$52.33M	$31.79M
YoY Change	64.61%
Cost Of Revenue	$17.46M	$12.38M
YoY Change	41.07%
Gross Profit	$34.86M	$19.41M
YoY Change	79.63%
Gross Profit Margin	66.63%	61.06%
Selling, General & Admin	$46.94M	$33.35M
YoY Change	40.77%
% of Gross Profit	134.65%	171.82%
Research & Development	$15.36M	$8.766M
YoY Change	75.21%
% of Gross Profit	44.06%	45.17%
Depreciation & Amortization	$1.600M	$900.0K
YoY Change	77.78%
% of Gross Profit	4.59%	4.64%
Operating Expenses	$62.30M	$42.11M
YoY Change	47.94%
Operating Profit	-$27.44M	-$22.70M
YoY Change	20.86%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$19.00K	$32.00K
YoY Change	-159.38%
Pretax Income	-$27.50M	-$22.67M
YoY Change	21.29%
Income Tax	$248.0K	$100.0K
% Of Pretax Income
Net Earnings	-$27.71M	-$22.75M
YoY Change	21.77%
Net Earnings / Revenue	-52.95%	-71.58%
Basic Earnings Per Share
Diluted Earnings Per Share	-$291.0K	-$251.1K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$224.2M
YoY Change
Cash & Equivalents	$221.7M	$39.71M
Short-Term Investments	$2.500M
Other Short-Term Assets	$23.40M
YoY Change
Inventory
Prepaid Expenses
Receivables	$32.17M
Other Receivables	$0.00
Total Short-Term Assets	$279.8M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$13.18M
YoY Change
Goodwill	$6.300M
YoY Change
Intangibles	$9.835M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.671M
YoY Change
Total Long-Term Assets	$40.43M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$279.8M
Total Long-Term Assets	$40.43M
Total Assets	$320.2M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.91M
YoY Change
Accrued Expenses	$6.600M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$143.1M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$6.323M
YoY Change
Total Long-Term Liabilities	$6.323M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$143.1M
Total Long-Term Liabilities	$6.323M
Total Liabilities	$154.3M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$317.0M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$165.9M
YoY Change
Total Liabilities & Shareholders Equity	$320.2M
YoY Change

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$27.71M	-$22.75M
YoY Change	21.77%
Depreciation, Depletion And Amortization	$1.600M	$900.0K
YoY Change	77.78%
Cash From Operating Activities	-$9.686M	-$15.04M
YoY Change	-35.58%
INVESTING ACTIVITIES
Capital Expenditures	$2.448M	$927.0K
YoY Change	164.08%
Acquisitions
YoY Change
Other Investing Activities	$11.90M	$3.000M
YoY Change	296.67%
Cash From Investing Activities	$8.217M	$841.0K
YoY Change	877.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$207.0K	$71.00K
YoY Change	191.55%
Cash From Financing Activities	$200.1M	-$337.0K
YoY Change	-59479.23%
NET CHANGE
Cash From Operating Activities	-$9.686M	-$15.04M
Cash From Investing Activities	$8.217M	$841.0K
Cash From Financing Activities	$200.1M	-$337.0K
Net Change In Cash	$198.7M	-$14.48M
YoY Change	-1471.91%
FREE CASH FLOW
Cash From Operating Activities	-$9.686M	-$15.04M
Capital Expenditures	$2.448M	$927.0K
Free Cash Flow	-$12.13M	-$15.96M
YoY Change	-23.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	dei	Amendment Flag AmendmentFlag	false
CY2017Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2017Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2017Q2	dei	Document Period End Date DocumentPeriodEndDate	2017-04-30
CY2017Q2	dei	Document Type DocumentType	10-Q
CY2017Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001660134
CY2017Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2017Q2	dei	Entity Registrant Name EntityRegistrantName	Okta, Inc.
CY2017Q1	okta	Cash Equivalentsand Availableforsale Securities Amortized Cost Basis CashEquivalentsandAvailableforsaleSecuritiesAmortizedCostBasis	24945000	USD
CY2017Q2	okta	Cash Equivalentsand Availableforsale Securities Amortized Cost Basis CashEquivalentsandAvailableforsaleSecuritiesAmortizedCostBasis	220151000	USD
CY2017Q1	okta	Cash Equivalentsand Availableforsale Securities Fair Value Disclosure CashEquivalentsandAvailableforsaleSecuritiesFairValueDisclosure	24955000	USD
CY2017Q2	okta	Cash Equivalentsand Availableforsale Securities Fair Value Disclosure CashEquivalentsandAvailableforsaleSecuritiesFairValueDisclosure	220151000	USD
CY2017Q1	okta	Deferred Sales Commissions Current DeferredSalesCommissionsCurrent	13549000	USD
CY2017Q2	okta	Deferred Sales Commissions Current DeferredSalesCommissionsCurrent	13131000	USD
CY2016Q2	okta	Deferred Stock Issuance Costs Incurred But Not Yet Paid DeferredStockIssuanceCostsIncurredButNotYetPaid	125000	USD
CY2017Q2	okta	Deferred Stock Issuance Costs Incurred But Not Yet Paid DeferredStockIssuanceCostsIncurredButNotYetPaid	1772000	USD
CY2016Q2	okta	Depreciation Amortizationand Accretion Excluding Amortizationof Deferred Sales Commissions DepreciationAmortizationandAccretionExcludingAmortizationofDeferredSalesCommissions	887000	USD
CY2017Q2	okta	Depreciation Amortizationand Accretion Excluding Amortizationof Deferred Sales Commissions DepreciationAmortizationandAccretionExcludingAmortizationofDeferredSalesCommissions	1575000	USD
CY2017Q2	okta	Sharebased Compensation Arrangementby Sharebased Payment Award Number Of Equity Incentive Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberOfEquityIncentivePlans	2	equity_incentive_plan
CY2016Q2	okta	Stock Issued For Warrants Exercised StockIssuedForWarrantsExercised	0	USD
CY2017Q2	okta	Stock Issued For Warrants Exercised StockIssuedForWarrantsExercised	272000	USD
CY2016Q2	okta	Vesting Of Early Exercised Common Stock Options VestingOfEarlyExercisedCommonStockOptions	356000	USD
CY2017Q2	okta	Vesting Of Early Exercised Common Stock Options VestingOfEarlyExercisedCommonStockOptions	328000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11897000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	15909000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34544000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32171000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-167000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-99000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	44469000	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	483019000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3369000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8906000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1306000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1025000	USD
CY2016Q2	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	3053000	USD
CY2017Q2	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	4039000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	83777000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	36876000	shares
CY2017Q1	us-gaap	Assets Assets	130635000	USD
CY2017Q2	us-gaap	Assets Assets	320230000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	92790000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	279799000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	14380000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2500000	USD
CY2017Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	14390000	USD
CY2017Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2500000	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	14380000	USD
CY2017Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2500000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1538000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1538000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	12842000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2500000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	12852000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2500000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	14390000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2500000	USD
CY2017Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	5	investment
CY2017Q2	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	1	investment
CY2016Q2	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	USD
CY2017Q2	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	2160000	USD
CY2016Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1183000	USD
CY2017Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1931000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39714000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23282000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	221726000	USD
CY2016Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58081000	USD
CY2016Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43597000	USD
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23282000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	221989000	USD
CY2016Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14484000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	198707000	USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22674000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28833000	USD
CY2016Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2017Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	228362000	USD
CY2016Q2	us-gaap	Cost Of Services CostOfServices	12379000	USD
CY2017Q2	us-gaap	Cost Of Services CostOfServices	17463000	USD
CY2016Q2	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	7460000	USD
CY2017Q2	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	11157000	USD
CY2017Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	4800000	USD
CY2017Q2	us-gaap	Deferred Rent Credit DeferredRentCredit	4900000	USD
CY2017Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	108012000	USD
CY2017Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	115717000	USD
CY2017Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5711000	USD
CY2017Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4927000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.22
CY2017Q1	us-gaap	Deferred Sales Commission DeferredSalesCommission	10050000	USD
CY2017Q2	us-gaap	Deferred Sales Commission DeferredSalesCommission	9463000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.73
CY2016Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47000	USD
CY2017Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68000	USD
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.009
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9866000	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6613000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	75200000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3367000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4033000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	12522000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13868000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9155000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9835000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6945000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11639000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	2600000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	2630000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	6282000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	6300000	USD
CY2016Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	19408000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	35544000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22700000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22672000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28653000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28700000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	81000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	248000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3681000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3782000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3090000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2243000	USD
CY2016Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-182000	USD
CY2017Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-223000	USD
CY2016Q2	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-2756000	USD
CY2017Q2	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-3033000	USD
CY2016Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2437000	USD
CY2017Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	6920000	USD
CY2016Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2855000	USD
CY2017Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2121000	USD
CY2017Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2200000	USD
CY2016Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2876000	USD
CY2017Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3143000	USD
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9155000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9835000	USD
CY2016Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1700000	USD
CY2017Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	5400000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	146286000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	154311000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	130635000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	320230000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	135628000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	143061000	USD
CY2016Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	27563000	USD
CY2017Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	48357000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-337000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	200108000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	841000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8217000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15035000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9686000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-22753000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-28901000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	42112000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	64178000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-22704000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-28634000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4984000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1671000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	32000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	47000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	68000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	79000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	68000	USD
CY2017Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5853000	USD
CY2017Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4822000	USD
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4947000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6323000	USD
CY2016Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	130000	USD
CY2017Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-270000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000	USD
CY2017	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2017Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2016Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	390000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11026000	USD
CY2017Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2564000	USD
CY2017Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	1538000	USD
CY2016Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	124000	USD
CY2017Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2246000	USD
CY2016Q2	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1232000	USD
CY2017Q2	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1208000	USD
CY2016Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	927000	USD
CY2017Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2448000	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7025000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10271000	USD
CY2016Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2017Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	199997000	USD
CY2016Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3000000	USD
CY2017Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10335000	USD
CY2016Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13180000	USD
CY2016Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	71000	USD
CY2017Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	207000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8766000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15359000	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3883000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	263000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-287909000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-317010000	USD
CY2016Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	31787000	USD
CY2017Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	53007000	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26401000	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	37180000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3369000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	8906000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12656317	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.57
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	14100000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	501308	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2596568	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.65
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.36
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	145570000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	664506000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	32866862	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.47
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4600000	USD
CY2017Q1	us-gaap	Short Term Investments ShortTermInvestments	14390000	USD
CY2017Q2	us-gaap	Short Term Investments ShortTermInvestments	2500000	USD
CY2017Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1022650	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	33939472	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.01
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	-243605000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.75
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.53
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.03
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	284473000	USD
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y9M18D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M16D
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M13D
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2700000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	165919000	USD
CY2016Q2	us-gaap	Technology Services Costs TechnologyServicesCosts	4919000	USD
CY2017Q2	us-gaap	Technology Services Costs TechnologyServicesCosts	6306000	USD
CY2016Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	4224000	USD
CY2017Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	4650000	USD
CY2017Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	227954000	USD
CY2017Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18574000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39783000	shares
CY2017Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates and judgments involve revenue recognition with respect to the determination of the relative selling prices for the Company’s services, determination of the fair value of the Company’s common stock prior to the completion of the IPO, valuation of the Company’s stock-based awards, valuation of deferred income tax assets and contingencies.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-17-006320-index-headers.html	Edgar Link	pending
0001628280-17-006320-index.html	Edgar Link	pending
0001628280-17-006320.txt	Edgar Link	pending
0001628280-17-006320-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
okta-04302017_10q.htm	Edgar Link	pending
okta-04302017_ex311.htm	Edgar Link	pending
okta-04302017_ex312.htm	Edgar Link	pending
okta-04302017_ex321.htm	Edgar Link	pending
okta-20170430.xml	Edgar Link	completed
okta-20170430.xsd	Edgar Link	pending
okta-20170430_cal.xml	Edgar Link	unprocessable
okta-20170430_def.xml	Edgar Link	unprocessable
okta-20170430_lab.xml	Edgar Link	unprocessable
okta-20170430_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OKTA
Okta Inc Stock $okta

2017 Q2 Form 10-Q Financial Statement

#000162828017006320 Filed on June 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OKTA Okta Inc Stock $okta

2017 Q2 Form 10-Q Financial Statement

#000162828017006320 Filed on June 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OKTA
Okta Inc Stock $okta